Hempseed oil nanoemulsions for oral delivery applications: Development and best practices
Emerging technologies designed to produce nanoemulsion formulations with improved characteristics, such as emulsion stability and uniform particle size, are becoming more widely adopted, but direct comparisons between methods are lacking.
On May 25, Anton Paar will host Dr. Farahnaz Fathordoobady and Dr. Natalia Sannikova for a live discussion on the recent report, Comparing microfluidics and ultrasonication as formulation methods for developing hempseed oil nanoemulsions for oral delivery applications. The report can be found at this link: https://www.nature.com/articles/s41598-020-79161-w
Specific topics will include:
• Study of oil in water nanoemulsions, based on hempseed oil (HSO)
• Emerging formulation technologies aimed to produce nanoemulsions with improved characteristics, including stability and oral delivery applications
• Formulation techniques such as ultrasound and microfluidic approaches
• Further analyses to assess the functionality of prepared formulations:
o Morphology examination
o Simulated gastrointestinal release behavior study
o Transepithelial transport evaluations
o Toxicity test
The event will feature a live question and answer session following the presentation to address specific questions.
2021-05-25, 13:00 - 14:00 (EDT UTC-04:00)
Trainer: Dr. Natalia Sannikova, Dr. Farahnaz Fathordoobady
Dr. Natalia Sannikova is a skilled chemist with experience in organic synthesis, enzymology, and nanoparticle formulation. She firmly believes that team effort and multidisciplinary research are what is needed for a successful project. Natalia holds a PhD in organic chemistry from Simon Fraser University.
Dr. Farahnaz Fathordoobady is a food scientist experienced in bioactive materials extraction, nano-encapsulation techniques, and oral delivery of nutraceuticals. She is a postdoctoral fellow in Food, Nutrition and Health, University of British Columbia. She is also a member of Highly Qualified Personnel (HQP) of Nanomedicines Innovation Network (NMIN).